Multiple Sclerosis Journal - Experimental, Translational and Clinical

SJR Rank #8,775H-index: 37SJR: 0.665Best quartile: Q2Open AccessAPC: US$2,650Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Inc.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Neurology (clinical)Q2
  • Cellular and Molecular NeuroscienceQ3

Areas: Medicine · Neuroscience

Most published research topics

Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersAmyotrophic Lateral Sclerosis ResearchPolyomavirus and related diseasesSystemic Sclerosis and Related DiseasesSystemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesBalance, Gait, and Falls PreventionCerebral Palsy and Movement DisordersLong-Term Effects of COVID-19

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04080120160

Documents per Year

20222025015304560

Detailed Information

ISSN

2055-2173

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

1.96

References per Document

33.21

Coverage

2015-2026

Scope

Multiple Sclerosis Journal – Experimental, Translational and Clinical is an international, peer reviewed, open access publication that augments the potential to publish across the broad spectrum of experimental, translational and clinical topics in Multiple Sclerosis. It facilitates the rapid publication of high quality papers in: • Emerging observations with translational potential not yet realised • Early validation of clinical outcome metrics • Pilot trials which may stimulate therapeutic innovation • Geographic focus which validate and add to existing studies • High specialised areas of experimental, translational and clinical research

Metrics from SCImago Journal Rank 2025. View on SCImago